Search Results - "del Mar Maldonado, Maria"

Refine Results
  1. 1

    Targeting Rac and Cdc42 GTPases in Cancer by Maldonado, María Del Mar, Dharmawardhane, Suranganie

    Published in Cancer research (Chicago, Ill.) (15-06-2018)
    “…Rac and Cdc42 are small GTPases that have been linked to multiple human cancers and are implicated in epithelial to mesenchymal transition, cell-cycle…”
    Get full text
    Journal Article
  2. 2

    Targeting Rac and Cdc42 GEFs in Metastatic Cancer by Maldonado, Maria Del Mar, Medina, Julia Isabel, Velazquez, Luis, Dharmawardhane, Suranganie

    “…The Rho family GTPases Rho, Rac, and Cdc42 have emerged as key players in cancer metastasis, due to their essential roles in regulating cell division and actin…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer by Borrero-García, Luis D, Del Mar Maldonado, Maria, Medina-Velázquez, Julia, Troche-Torres, Angel L, Velazquez, Luis, Grafals-Ruiz, Nilmary, Dharmawardhane, Suranganie

    Published in BMC cancer (01-06-2021)
    “…Even though targeted therapies are available for cancers expressing oncogenic epidermal growth receptor (EGFR) and (or) human EGFR2 (HER2), acquired or…”
    Get full text
    Journal Article
  6. 6

    A Standardized Extract of Lentinula edodes Cultured Mycelium Inhibits Pseudomonas aeruginosa Infectivity Mechanisms by Tena-Garitaonaindia, Mireia, Ceacero-Heras, Diego, Montoro, María Del Mar Maldonado, de Medina, Fermín Sánchez, Martínez-Augustin, Olga, Daddaoua, Abdelali

    Published in Frontiers in microbiology (16-03-2022)
    “…The priority pathogen list of the World Health Organization classified as the second top critical pathogen. Hence, the development of novel antibacterial…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice by Reig-López, Javier, Maldonado, María Del Mar, Merino-Sanjuan, Matilde, Cruz-Collazo, Ailed M, Ruiz-Calderón, Jean F, Mangas-Sanjuán, Victor, Dharmawardhane, Suranganie, Duconge, Jorge

    Published in Pharmaceutics (15-10-2020)
    “…MBQ-167 is a dual inhibitor of the Rho GTPases Rac and Cdc42 that has shown promising results as an anti-cancer therapeutic at the preclinical stage. This drug…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment by Maldonado, Maria del Mar, Schlom, Jeffrey, Hamilton, Duane H.

    Published in Cancer Immunology, Immunotherapy (01-10-2023)
    “…The macrophage colony-stimulating factor 1 (CSF1) is a chemokine essential for the survival, proliferation, and differentiation of mononuclear phagocytes from…”
    Get full text
    Journal Article
  14. 14

    Abstract 623: Investigating potential off-target effects of the dual Rac and Cdc42 inhibitor MBQ-167 by Picon, Hector M., Maldonado, Maria Del Mar, Flanagan, Surangani F. Dharmawardhane

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Metastasis is a major cause of death in epithelial cancers, largely because of a lack of effective treatments. The metastatic inhibitor MBQ-167 was developed…”
    Get full text
    Journal Article
  15. 15

    Impact of a risk-sharing agreement in rheumatoid arthritis in Spain by García-Collado, Carlos Gustavo, Martínez-de-la-Plata, Juan Enrique, Montoro, María del Mar Maldonado, Morales, Alberto Jiménez, Hernández, Miguel Ángel Calleja, Martínez, Fernando Martínez

    Published in Health policy (Amsterdam) (01-03-2021)
    “…•The effectiveness of new drugs may differ from efficacy in clinical trials.•Adequately designed RSAs are useful instruments for the sustainability of…”
    Get full text
    Journal Article
  16. 16

    Abstract 5085: Blockade of tumor derived CSF1 promotes an immune-permissive tumor microenvironment by Maldonado, Maria Del Mar, Hamilton, Duane H., Schlom, Jeffrey

    Published in Cancer research (Chicago, Ill.) (04-04-2023)
    “…The macrophage colony stimulating factor 1 (CSF1) is a chemokine essential for the survival, proliferation, and differentiation of especially mononuclear…”
    Get full text
    Journal Article
  17. 17

    Sensitization of Anti‐EGFR/HER2 Targeted Therapy Resistance in Breast Cancer Cells by MiRNA Manipulation by Vigo‐Morales, Paula Rocío, Borrero‐Garcia, Luis Daniel, Del Mar Maldonado, Maria, Dharmawardhane, Suranganie

    Published in The FASEB journal (01-04-2019)
    “…The aim of this study is to explore the resistance mechanisms to anti‐epidermal growth factor receptor (EGFR) and anti‐human epidermal growth factor receptor…”
    Get full text
    Journal Article
  18. 18

    Abstract 3020: Tumor pharmacokinetics of the metastatic cancer inhibitor MBQ-167 in mice by Del Mar Maldonado, Maria, Cruz-Collazo, Ailed M., Borrero-García, Luis D., Rosado-González, Gabriela T., Ruiz-Calderon, Jean F., Duconge, Jorge, Dharmawardhane, Suranganie

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…The Rho GTPases Rac and Cdc42 are potential targets against metastatic disease. Our group characterized the small molecule MBQ-167 as an effective dual…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Overcoming Resistance to Anti‐EGFR Therapy in Breast Cancer with Rac Inhibitors by Borrero‐Garcia, Luis Daniel, Troche‐Torres, Angel Luis, Maldonado, Maria del Mar, Dharmawardhane, Suranganie

    Published in The FASEB journal (01-04-2017)
    “…Abstract only Epidermal growth factor receptor (EGFR) and human EGFR2 (HER2) targeted therapies have been successfully used in breast cancers that overexpress…”
    Get full text
    Journal Article